Learning Objectives:

• Define evidence-based value analysis and its role in selecting products that support SSI prevention and safety.
• Identify key data sources and metrics used to evaluate products for infection prevention effectiveness.
• Discuss strategies for aligning product selection decisions with organizational goals of quality, safety, and fiscal responsibility.

Program Description:

Product selection decisions in the perioperative environment must balance innovation, safety, cost, and clinical outcomes. This program examines how evidence-based value analysis supports the selection and evaluation of products that can demonstrably reduce SSI risk. Participants will learn how to assess research quality, interpret infection prevention data, and collaborate with value analysis and supply chain leaders to ensure decisions are rooted in evidence and aligned with organizational priorities and AHVAP recommendations. The session will highlight examples of products and technologies that improve patient outcomes.

Speaker:

J. Hudson Garrett Jr., Ph.D., MSN, MPH, MBA, FNP-BC, IP-BC, PLNC, CFER, AS-BC, VA-BC, HACP-IC, CMRP, LTC-CIP, CIC, AL-CIP, CPPS, CPHQ, CVAHP, CPXP, CPHRM, CHIPP-B, FAAPM, eFACHDM, FAPIC, FAOM, FRSPH, FNAP, FAHVAP, FACHE, FSHEA, FIDSA
Adjunct Assistant Professor, Division of Infectious Diseases
Department of Medicine
University of Louisville School of Medicine

Dr. Garrett is an Adjunct Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Louisville School of Medicine. He is Board Certified in Infection Prevention and Control, Advanced Leadership in Infection Control, Patient Safety, Healthcare Risk Management, and Healthcare Management and Leadership. Dr. Garrett is a Liaison to the AORN Guidelines Advisory Board.